Larotrectinib Capsules and Levalbuterol HFA Aerosol
Determining the interaction of Larotrectinib Capsules and Levalbuterol HFA Aerosol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Levalbuterol, Levalbuterol inhalation
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Levalbuterol inhalation
- Larotrectinib Capsules-Levalbuterol Inhalation Aerosol
- Larotrectinib Capsules-Levalbuterol Inhalation Solution
- Larotrectinib Capsules-Levalbuterol Inhalation Solution Concentrate
- Larotrectinib Capsules-Levalbuterol Inhalation, oral/nebulization
- Larotrectinib Capsules-Levamisole
- Levalbuterol HFA Aerosol-Larotrectinib Oral Solution
- Levalbuterol HFA Aerosol-Larotrectinib Sulfate
- Levalbuterol HFA Aerosol-Lartruvo
- Levalbuterol HFA Aerosol-Larynex
- Levalbuterol HFA Aerosol-Laryng-O-Jet
- Levalbuterol HFA Aerosol-Laryngesic